NAD+ supplements are one of the hottest products in the longevity space. Brands promise everything from reversed aging to restored energy. The molecule is real, the science behind it is legitimate — but the marketing has gotten far ahead of the evidence. Here’s what human clinical trials actually show.

What Is NAD+ and Why Does It Matter?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell in your body. It plays a central role in energy metabolism, DNA repair, and the activity of sirtuins — a family of proteins linked to aging and stress resistance1.

The problem: NAD+ levels decline with age. By middle age, tissue levels can drop to roughly half of what they were in youth2. This decline is associated with many hallmarks of aging — mitochondrial dysfunction, inflammation, and impaired DNA repair.

This observation launched a billion-dollar supplement industry. The logic is straightforward: if falling NAD+ contributes to aging, raising it back up should slow or reverse the process. The two main supplements on the market are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — both precursors that the body converts into NAD+.

The logic is sound. But does it actually work in humans?

The Key Human Trials

NMN: Yoshino et al. (2021)

This is the most cited NMN study in humans. Researchers at Washington University gave 250 mg of NMN daily to 25 postmenopausal, prediabetic women for 10 weeks in a randomized, placebo-controlled trial3.

The results:

  • Muscle insulin sensitivity improved by ~25% in the NMN group compared to placebo
  • NMN increased NAD+ metabolites in blood and muscle tissue
  • No significant changes in body weight, blood pressure, or blood lipids

This was a meaningful finding — insulin resistance is a major driver of metabolic aging. But the study was small (25 participants), short (10 weeks), and limited to one specific population. The authors themselves cautioned against broad conclusions.

NR: Martens et al. (2018) — The CROSSROADS Trial

This crossover trial gave 1,000 mg of NR daily for 6 weeks to 24 healthy middle-aged and older adults (55–79 years)4.

Key findings:

  • NR raised blood NAD+ levels by ~60%
  • Systolic blood pressure dropped by ~2–4 mmHg in participants with elevated baseline blood pressure
  • There was a trend toward reduced arterial stiffness
  • The supplement was well tolerated with no serious side effects

Promising, but again — small sample, short duration, and the blood pressure effect was modest and only reached significance in a subgroup.

NR: Elhassan et al. (2019)

Researchers gave 1,000 mg of NR daily for 21 days to 12 older men (average age 75)5. Muscle biopsies showed:

  • NAD+ levels in skeletal muscle increased significantly
  • There was a decrease in inflammatory cytokines in muscle tissue
  • Participants reported reduced drowsiness and improved lower-limb function

Again — very small sample, no placebo control arm, and just three weeks long. Encouraging preliminary data, not proof.

NR: Dollerup et al. (2018) — A Negative Result

Not all trials have been positive. This Danish study gave 2,000 mg of NR daily for 12 weeks to 40 obese, insulin-resistant men6. The result:

  • NR did raise NAD+ metabolites in blood
  • But there was no improvement in insulin sensitivity, resting energy expenditure, or body composition compared to placebo

This is an important counterpoint. Raising NAD+ levels in the blood doesn’t automatically translate to metabolic benefits. The context — who takes it, their baseline health, the dose — clearly matters.

What We Actually Know

Here’s an honest summary of where the evidence stands:

What’s well established:

  • NAD+ declines with age — this is consistently shown across multiple studies
  • Both NMN and NR reliably raise NAD+ levels in blood and at least some tissues
  • Both supplements appear safe and well tolerated in trials up to 12 weeks

What’s promising but unproven:

  • Improved insulin sensitivity (shown in one small NMN trial)
  • Modest blood pressure reduction (shown in one small NR trial)
  • Reduced muscle inflammation (shown in one very small NR trial)

What’s unknown:

  • Whether raising NAD+ actually extends human lifespan — no trial has tested this
  • Long-term safety beyond 12 weeks
  • Optimal dosing — studies have used anywhere from 250 mg to 2,000 mg daily
  • Whether NMN or NR is more effective (no head-to-head trial exists)
  • Whether the benefits seen in specific populations generalize to healthy adults

The animal data is far more dramatic — in mice, NAD+ precursors have improved metabolic health, endurance, and even reversed some markers of aging7. But mice are not humans, and the history of anti-aging supplements is littered with compounds that worked in rodents but failed in people.

Why This Matters

The NAD+ story is a good example of legitimate science being oversold. The underlying biology is solid. The decline of NAD+ with age is real and probably contributes to aging. The precursor supplements do raise NAD+ levels. But the leap from “raises a biomarker” to “reverses aging” is enormous, and the human data simply isn’t there yet.

For a broader overview of longevity interventions ranked by evidence strength, see our evidence-based longevity guide.

That said, the early results are more encouraging than most supplement categories. If larger, longer trials confirm the insulin sensitivity and cardiovascular benefits, NAD+ precursors could become one of the better-supported longevity interventions. We’re just not there yet.

What You Can Do

1. Don’t Rely on Supplements Alone

The most proven ways to maintain NAD+ levels are free: regular exercise and caloric moderation both upregulate NAD+ biosynthesis naturally8. Exercise, in particular, activates NAMPT — the rate-limiting enzyme in NAD+ production. If you’re not exercising regularly, a pill won’t compensate.

2. If You Supplement, Set Realistic Expectations

If you want to try NMN or NR, go in with clear eyes. Studies suggest they raise NAD+ levels and are safe in the short term. A reasonable starting dose based on the clinical literature is 250–500 mg of NMN or 300–1,000 mg of NR daily. Look for third-party tested products — the supplement market is poorly regulated.

3. Prioritize Sleep

NAD+ metabolism follows a circadian rhythm — levels fluctuate with your sleep-wake cycle9. Chronic sleep disruption impairs NAD+-dependent repair processes. Consistent sleep of 7–9 hours supports the biological systems that NAD+ supplements are trying to boost.

4. Watch the Science

This field is moving fast. Several larger clinical trials are currently underway. Within the next few years, we should have much better data on whether NAD+ precursors deliver meaningful health benefits in humans. The current evidence is a reason for cautious interest, not for spending hundreds of dollars a month.

The Bottom Line

NAD+ is a real and important molecule. Its decline with age is well documented. Supplements that raise it are safe and effective at boosting blood levels. But we don’t yet have strong evidence that this translates to longer life, less disease, or reversed aging in humans. The early trial results are promising — particularly for metabolic health — but the studies are small, short, and mixed.

If you’re going to try NAD+ precursors, treat them as an experiment, not a guarantee. And don’t skip the basics — exercise, sleep, and a decent diet do more for longevity than any supplement with current evidence behind it.

Frequently Asked Questions

Does NMN actually increase NAD+ levels in humans?
Yes — this is one of the most consistent findings in the clinical literature. Multiple trials show that both NMN and NR reliably raise NAD+ levels in blood by 40–60%. What’s less clear is whether those higher blood levels translate to meaningful health benefits.
Is NMN better than NR?
No head-to-head human trial has compared them directly. Both raise blood NAD+ levels effectively. NMN has slightly more clinical data on metabolic effects; NR has more data on cardiovascular markers. Choose based on price and availability until more comparative data exists.
What are the side effects of NAD+ supplements?
Short-term trials (up to 12 weeks) report that both NMN and NR are well tolerated with no serious side effects. Some people report mild nausea or flushing at higher doses. Long-term safety data beyond 12 weeks does not yet exist in humans.
How long does it take for NMN or NR to work?
Blood NAD+ levels rise within days of starting supplementation. Metabolic effects — such as the insulin sensitivity improvement seen in the Yoshino 2021 trial — were measured at 10 weeks. Whether any benefit persists long-term is unknown.
Can I boost NAD+ naturally without supplements?
Yes. Regular aerobic exercise activates NAMPT, the rate-limiting enzyme in NAD+ biosynthesis, and is the most proven way to maintain NAD+ levels. Consistent sleep also supports the circadian-regulated NAD+ salvage pathway. These interventions have stronger long-term evidence than any supplement.

This article is for informational purposes only and does not constitute medical advice.


  1. Verdin, E. “NAD+ in aging, metabolism, and neurodegeneration.” Science, Volume 350, Issue 6265, 2015. https://doi.org/10.1126/science.aac4854 ↩︎

  2. Camacho-Pereira, J., Tarragó, M.G., Chini, C.C.S. et al. “CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.” Cell Metabolism, Volume 23, Issue 6, 2016. https://doi.org/10.1016/j.cmet.2016.05.006 ↩︎

  3. Yoshino, M., Yoshino, J., Kayser, B.D. et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science, Volume 372, Issue 6547, 2021. https://doi.org/10.1126/science.abe9985 ↩︎

  4. Martens, C.R., Denman, B.A., Mazzo, M.R. et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nature Communications, Volume 9, 2018. https://doi.org/10.1038/s41467-018-03421-7 ↩︎

  5. Elhassan, Y.S., Kluckova, K., Fletcher, R.S. et al. “Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.” Cell Reports, Volume 28, Issue 7, 2019. https://doi.org/10.1016/j.celrep.2019.07.043 ↩︎

  6. Dollerup, O.L., Christensen, B., Svart, M. et al. “A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.” The American Journal of Clinical Nutrition, Volume 108, Issue 2, 2018. https://doi.org/10.1093/ajcn/nqy132 ↩︎

  7. Mills, K.F., Yoshida, S., Stein, L.R. et al. “Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.” Cell Metabolism, Volume 24, Issue 6, 2016. https://doi.org/10.1016/j.cmet.2016.09.013 ↩︎

  8. de Guia, R.M., Agerholm, M., Nielsen, T.S. et al. “Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle.” Physiological Reports, Volume 7, Issue 12, 2019. https://doi.org/10.14814/phy2.14139 ↩︎

  9. Nakahata, Y., Sahar, S., Astarita, G. et al. “Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1.” Science, Volume 324, Issue 5927, 2009. https://doi.org/10.1126/science.1170803 ↩︎